Pathstone Family Office’s Chemed CHE Stock Holding History

Pathstone Family Office’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.42M	Buy	2,728 +264	+11%	+$137K	0.01%	572
2023 Q2	$1.35M	Buy	2,464 +140	+6%	+$76.5K	0.02%	396
2023 Q1	$1.23M	Sell	2,324 -3,262	-58%	-$1.66M	0.02%	390
2022 Q4	$2.54M	Buy	5,586 +768	+16%	+$374K	0.02%	430
2022 Q3	$2.1M	Buy	4,818 +3,467	+257%	+$1.67M	0.02%	426
2022 Q2	$634K	Sell	1,351 -150	-10%	-$73.2K	0.01%	486
2022 Q1	$1.05M	Sell	1,501 -152	-9%	-$72.9K	0.02%	314
2021 Q4	$875K	Sell	1,653 -151	-8%	-$72.5K	0.02%	370
2021 Q3	$839K	Buy	1,804 +443	+33%	+$209K	0.02%	346
2021 Q2	$645K	Buy	+1,361	New	+$654K	0.02%	395
2021 Q1	–	Sell	-1	Closed	-$1K	–	784
2020 Q4	$1K	Hold	1	–	–	﹤0.01%	1074
2020 Q3	$0	Hold	1	–	–	﹤0.01%	817
2020 Q2	$0	Buy	+1	New	+$446	﹤0.01%	748

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pathstone Family Office's CHE Position: Q3 2023 in Review

Pathstone Family Office increased its Chemed (CHE) stake by 11% in Q3 2023, buying an estimated $137K and bringing the position to 2,728 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #572.

Pathstone Family Office first reported a position in CHE in Q2 2020 and has held it in 13 quarters since. The position peaked at $2.54M in Q4 2022. 456 funds tracked by Wall St. Rank hold CHE as of Q3 2023.

Pathstone Family Office held 2,728 shares of Chemed worth $1.42M as of Q3 2023.
Pathstone Family Office bought 264 Chemed shares in Q3 2023, an estimated $137K.
Chemed made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #572 holding.
Pathstone Family Office first reported a position in Chemed in Q2 2020 and has held it in 13 quarters since.
Pathstone Family Office's Chemed position peaked at $2.54M in Q4 2022.
456 funds tracked by Wall St. Rank held Chemed as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.